Nova Leap Health Corp

Nova Leap Health Corp maintains a relatively strong liquidity position, with a current ratio of 1.78, indicating the company can cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to $1,116,760, while its long-term debt is $1,248,940, resulting in a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.07 suggests a conservative capital structure with minimal leverage. In terms of profitability, the company's return on equity (ROE) is 2.59%, and its return on assets (ROA) is 2.27%, both of which are below the industry median for healthcare facilities and services. The operating margin is 3.36%, and the net profit margin is 7.35%, indicating that the company is generating a modest profit relative to its revenue. The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks. The company's growth trajectory is not clearly defined in the available data, as there are no specific revenue growth projections or historical growth rates provided. The capital expenditure for the period is reported as $0, suggesting that the company is not currently investing in new physical assets. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to fund operations without external financing. The dilution risk is low, and there are no significant adjustments applied to the valuation metrics. Recent events, such as analyst estimates, show that the last actual EPS was -$0.01, and the last actual revenue was $35,325,000. These figures suggest that the company is currently reporting a small loss per share, which may impact investor sentiment and stock performance.